Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Predicting LVEF Improvement After AF Catheter Ablation
Author(s): Nikhil Ahluwalia , Ahmed Hussain , Rui Providencia , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Heart Failure
RELAXIN-LA Trial: Volenrelaxin Linked to Worsening Congestion in HFpEF
Added: 9 months ago Source:  Radcliffe Cardiology
Treatment with volenrelaxin, a long-acting human relaxin analogue, was associated with worsening congestion in patients with recently decompensated heart failure with preserved ejection fraction (HFpEF), leading to the early termination of the phase 2 RELAXIN-LA trial.¹ Despite this, the lowest dose of the drug did show an improvement in the study's primary endpoint.Relaxin is a peptide hormone… View more

Imaging & Diagnostics

Cardiovascular Kidney Metabolic
David A Baran
Research Area(s) / Expertise:
Personal History Dr David Alan Baran is a Cardiologist from Parsippany, New Jersey. He is married and based in Norfolk, Virginia. Academic History In 1988, Dr Baran received his Bachelor’s (Hon) in Chemistry from Florida Atlantic University, followed by an M.D. from the University of South Florida Morsani College of Medicine in 1992. He finished his Residency at NY Presbyterian… View more
Social Factors Impact Outcomes in HCM Patients
Added: 5 months ago Source:  Radcliffe Cardiology
While social determinants of health (SDOH) are known to influence outcomes in acquired cardiovascular diseases, their impact on conditions with a strong genetic basis, such as hypertrophic cardiomyopathy (HCM), has been less clear.² A new study using data from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) suggests that area-based social factors are independently associated with adverse… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
Genetic Link to CVD in Hypertensive Pregnancy
Added: 7 months ago Source:  Radcliffe Cardiology
Observational studies have long suggested that women who experience hypertensive disorders of pregnancy (HDP) face a greater risk of cardiovascular disease (CVD) later in life. A new genetic epidemiological study has explored whether this association is causal, using Mendelian randomization (MR) to investigate the genetic underpinnings of this risk. The findings suggest a genetic predisposition… View more

MI/ACS

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Cardiologist
Dr Michel Komajda is a Cardiologist at theNational Academy of Medicine in Paris, France.He is a past president of the European Society of Cardiology and the French Cardiac Society.He has been a member of the steering comittee, clinical endpoint committee or DSMB of many notable heart failure clinical trials, including SHIFT, CORONA, I PRESERVE, COMET, PARADIGM HF, CARMEN, EMPHESUS, RENAISSANCE,… View more
Between the Sessions with Dr Parwani: VESALIUS-CV, KARDINAL, CHIP-BCIS3 & M
Author(s): Purvi Parwani Added: 3 months ago
Dr Purvi Parwani (Loma Linda University Health, US) recaps the standout science from Day 2 of ACC 2026, a day defined by a central theme: challenging long-held assumptions in cardiology. Her summary focuses on what these updates mean for day-to-day clinical practice, from prevention strategies to interventional decision-making.Prevention and Risk ReductionVESALIUS-CV: Showed a 25% reduction in… View more

Intervention

Prevention & Chronic Conditions
Frailty in Cardio-oncology
Author(s): Ilaria Torre , Lorenzo Tinti , Ludovica Amore , et al Added: 4 months ago

CV Disease in Special Populations

Heart Failure
Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease
Author(s): Federica Piani , Lorenzo Annesi , Claudio Borghi Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
The Future of Heart Valve Treatment: Proven Therapies and Patient Impact
Author(s): Brian O’Neill, Bryan Zweig, Ryan Gindi Start date: Apr 04, 2025
Join us for an exclusive webinar, part of the Beyond the Heartbeat series, that delves into the latest advancements in mitral and tricuspid regurgitation treatment. Our expert panel will equip you with details related to groundbreaking clinical trial data and practical insights to enhance your professional practice.Learning Objectives:Explore Proven Therapies: Discover recent clinical data from… View more

Intervention

Guidelines & Statements